Literature DB >> 11061622

Is there a range of time for initiation of adjuvant chemotherapy in patients with malignancy?

M K Altundağ, I Celik, Y Ozişik.   

Abstract

Entities:  

Mesh:

Year:  2000        PMID: 11061622     DOI: 10.1023/a:1008339804441

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

1.  Optimal timing of adjuvant treatment in patients with early breast cancer.

Authors:  Necati Alkis; Ayse G Durnali; Ulku Y Arslan; Murat Kocer; Fatih O Onder; Saadet Tokluoglu; Gokhan Celenkoglu; Sadik Muallaoglu; Gungor Utkan; Arife Ulas; Kadri Altundag
Journal:  Med Oncol       Date:  2010-05-15       Impact factor: 3.064

2.  Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG).

Authors:  S Cold; M Düring; M Ewertz; A Knoop; S Møller
Journal:  Br J Cancer       Date:  2005-09-19       Impact factor: 7.640

3.  Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer?

Authors:  C Alliot
Journal:  Br J Cancer       Date:  2006-03-27       Impact factor: 7.640

Review 4.  Association between delayed initiation of adjuvant CMF or anthracycline-based chemotherapy and survival in breast cancer: a systematic review and meta-analysis.

Authors:  Ke-Da Yu; Sheng Huang; Jia-Xin Zhang; Guang-Yu Liu; Zhi-Ming Shao
Journal:  BMC Cancer       Date:  2013-05-16       Impact factor: 4.430

5.  Survival and time to initiation of adjuvant chemotherapy among breast cancer patients: a systematic review and meta-analysis.

Authors:  Qiao-Hui Zhan; Jian-Qin Fu; Fang-Meng Fu; Jie Zhang; Chuan Wang
Journal:  Oncotarget       Date:  2017-12-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.